EQT Walks Away From Takeover Bid for UK’s Oxford Biomedica plc
Decision Announced on Feb 25, 2026
EQT Ends Oxford Biomedica Takeover Talks
Feb 25 (Reuters) - Private equity group EQT said on Wednesday it had decided not to proceed with a takeover offer for Oxford Biomedica, sending the British cell and gene therapy manufacturer's shares down nearly 10%.
Byline and Attribution
(Reporting by Ankita Bora in Bengaluru; Editing by Shreya Biswas)
